Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8532 USD | -7.47% | -12.64% | -58.18% |
Apr. 16 | Scilex Issues Preliminary Q1 Sales Results for ZTlido | MT |
Mar. 20 | Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.18% | 112M | |
+3.37% | 69.85B | |
+11.77% | 8.98B | |
-12.75% | 4.89B | |
+42.38% | 4.44B | |
+5.23% | 3.95B | |
+21.69% | 2.49B | |
-19.05% | 2.4B | |
-28.72% | 2.28B | |
+11.13% | 1.96B |
- Stock Market
- Equities
- SCLX Stock
- News Scilex Holding Company
- Scilex Issues Preliminary Q1 Sales Results for ZTlido